greeksoup/ stocks
Stocks / Foreign companies / ICLR · Services-Commercial Physical & Biological Research

ICON plc (ICLR)

ICON plc files a 20-F with the SEC once a year, in US dollars. In the year to 31 December 2025 it reported revenue of USD 8,251 million, up 0.8% on the year before. Its profit attributable to shareholders was USD 229 million, down 69.0%, and diluted earnings per share USD 2.90.

Earnings per share are per ordinary share, in US dollars. The share that trades in the US can be a depositary share standing for more or fewer ordinary shares, so no price ratio is worked out on this page.

The public record on ICLR

Planned insider sales16 Form 144 notices in twelve months, $8.2 million; latest 17 September 2026
Options tapeput/call 0.46 by open interest on 26 September 2026; the straddle prices a 8.6% move to 16 October 2026
Holders9 of the followed funds hold it; largest FMR LLC; 11 Schedule 13D or 13G filings in twelve months
Congress2 House trades disclosed in six months
Short interest2.6 million shares short, 2.77 days to cover at 15 September 2026

Profit and loss, 12 fiscal years

Year toDec 2025Dec 2024*Dec 2023*Dec 2022*Dec 2021Dec 2020*Dec 2019*Dec 2018Dec 2017Dec 2016Dec 2015Dec 2014
Revenue8,2518,1898,0557,7415,4812,7972,8062,5961,7581,6661,5751,503
Cost of salesn/a5,8455,7205,5273,9731,9801,9741,8181,027961909903
Selling, general and administrative780728769779585342333326324326327336
Operating profit4431,032905795379392433373338312282202
Profit before tax252804573568197381427365328300279203
Income tax23.164.618.459.441.347.951.142.046.638.039.330.2
Profit for the year229739554505153333376323281n/an/an/a
Profit attributable to shareholders229739554505153332374323281262240172

USD million, from each year's annual report on the SEC's EDGAR, the year linked to its filing, on the US GAAP tags the company filed. A line the company does not file under the standard tag is left out rather than estimated. A year marked * shows the figure as the company restated it in a later annual report (Dec 2019, Dec 2020, Dec 2022, Dec 2023, Dec 2024); the first-filed figure is in the CSV. Profit for the year includes the part that belongs to minority shareholders; profit attributable to shareholders is the part EPS is struck on.

Year toDec 2025Dec 2024*Dec 2023*Dec 2022*Dec 2021Dec 2020*Dec 2019*Dec 2018Dec 2017Dec 2016Dec 2015Dec 2014
Diluted EPS2.908.906.706.132.256.156.795.895.134.653.972.73
Basic EPS2.928.966.756.202.286.206.855.965.204.754.082.80

USD per ordinary share, as filed.

Cash flow

Year toDec 2025Dec 2024*Dec 2023*Dec 2022*Dec 2021Dec 2020*Dec 2019*Dec 2018Dec 2017Dec 2016Dec 2015Dec 2014
Cash from operations1,0361,2871,161563829568413269383259279170
Purchase of property, plant and equipment17416814114293.840.938.948.444.742.649.732.8
Free cash flow8621,1191,020421735527374220338217229137

USD million. Purchase of property, plant and equipment is the cash line as filed; purchases of intangible assets and acquisitions are not in it. Free cash flow is cash from operations less that purchase, arithmetic on the two filed lines.

Balance sheet at year end

Year toDec 2025Dec 2024*Dec 2023*Dec 2022*Dec 2021Dec 2020*Dec 2019*Dec 2018Dec 2017Dec 2016Dec 2015Dec 2014
Total assets16,27016,63516,86517,18517,3873,4362,9082,3542,1471,8261,7171,529
Equity attributable to shareholders9,1939,4419,2118,5278,0671,8501,6181,3541,191945763950
Cash and cash equivalents647539378289752840520396283193104119
Trade and other receivables1,4751,3931,7641,7311,343715528415380416409371
Inventoriesn/an/an/an/a5.84.83.22.32.22.41.81.7
Goodwill8,7329,0519,0228,9729,038936883756769616588463

USD million, at each fiscal year end. Borrowings is the company's own stated total where it files one; it is never added up from its parts here.

Ratios on the filed lines

Year toDec 2025Dec 2024*Dec 2023*Dec 2022*Dec 2021Dec 2020*Dec 2019*Dec 2018Dec 2017Dec 2016Dec 2015Dec 2014
Operating margin5.4%12.6%11.2%10.3%6.9%14.0%15.4%14.4%19.2%18.7%17.9%13.5%
Net margin2.8%9.0%6.9%6.5%2.8%11.9%13.3%12.4%16.0%15.7%15.2%11.5%
Free cash flow margin10.4%13.7%12.7%5.4%13.4%18.8%13.3%8.5%19.2%13.0%14.6%9.1%
Return on year-end equity2.5%7.8%6.0%5.9%1.9%18.0%23.1%23.8%23.6%27.7%31.4%18.2%
Effective tax rate9.2%8.0%3.2%10.5%21.0%12.6%12.0%11.5%14.2%12.7%14.1%14.9%

Arithmetic on the filed lines of the same year: margins over revenue, return on equity as profit attributable to shareholders over year-end equity, tax over profit before tax.

Annual reports on EDGAR

FormYear toFiled
20-F31 December 202527 May 2026EDGAR
20-F31 December 202421 February 2025EDGAR
20-F31 December 202323 February 2024EDGAR
20-F31 December 202224 February 2023EDGAR
20-F31 December 20211 March 2022EDGAR
20-F31 December 202024 February 2021EDGAR
20-F31 December 201927 February 2020EDGAR
20-F31 December 20181 March 2019EDGAR
20-F31 December 201728 February 2018EDGAR
20-F31 December 201628 February 2017EDGAR
20-F/A31 December 201516 June 2016EDGAR
20-F31 December 201523 March 2016EDGAR

The same record on your computer

GreekSoup is also a free program for your own computer. It reads these same filings for the names you follow, refreshed as they land, with no account. One pasted line installs it.

Install